Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma
β Scribed by David J. Easty; Philip J. Mitchell; Ketan Patel; Vivi Ann Florenes; Richard A. Spritz; Dorothy C. Bennett
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- French
- Weight
- 172 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We have previously shown that 2 human melanoma cell lines, the metastatic HT-144 and the non-metastatic SK-Mel-2 cells, exhibit marked in vitro heterogeneity with respect to integrin expression, migration and invasion potential. Here, we provide evidence that HT-144 melanoma cells, but not SK-Mel-2
The effect of tyrosine kinase inhibitor, erbstatin, on cell growth and mRNA expression of growth-factor/receptor system was examined in 6 human gastric-carcinoma cell lines. Erbstatin inhibited both EGF-induced and serum-stimulated cell growth of all 6 cell lines (TMK-I, MKN-I, -7, -28, -45, -74) in
Work in animal models has suggested that interactions of members of the 87 receptor family (e.g., 87-I, 87-2) on tumor cells with their ligands CD28 and CTLA-4 on cytotoxic T cells (CTL) are important for the induction of anti-tumor immunity against malignant melanoma (MM). To determine whether thes